Particle size and zeta potential investigation of synthetic peptide-protein conjugates;Sentetik peptid-protein konjugatlarının parçacık boyutu ve zeta potensiyel analizi

Turkish Journal of Biochemistry

Volumn 40, Issue 4, 2015, Pages 282-289

  Derman, Serap ^a   Akdeste, Zeynep Mustafaeva ^a  

^a ISTANBUL TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Bovine serum albumin; Conjugation; Foot and mouth disease; Particle size; Synthetic peptide; Zeta potential

Indexed keywords

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; BOVINE SERUM ALBUMIN; PEPTIDES AND PROTEINS; PROTEIN VP1; SYNTHETIC PEPTIDE PROTEIN CONJUGATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONJUGATION; CRYSTAL STRUCTURE; ELECTRIC FIELD; ELECTROPHORESIS; ELECTROPHORETIC MOBILITY; FOOT AND MOUTH DISEASE VIRUS; LIGHT SCATTERING; MOLECULAR MODEL; PARTICLE SIZE; PROTEIN DATA BANK; PROTEIN STRUCTURE; ZETA POTENTIAL;

BOVINAE; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 84939478849     PISSN: 02504685     EISSN: 1303829X     Source Type: Journal    
DOI: 10.1515/tjb-2015-0014     Document Type: Article

References (33)

1. Lateef SS, Gupta S, Jayathilaka LP, Krishnanchettiar S, Huang JS, et al. An improved protocol for coupling synthetic peptides to carrier proteins for antibody production using DMF to solubilize peptides. J Biomol Tech 2007; 18(3):173–6.
2. Derman S, Kizilbey K, Mansuroglu B, Mustafaeva Z. Synthesis and characterization of canine parvovirus (CPV) VP2 W-7L-20 synthetic peptide for synthetic vaccine. Fresen Environ Bull 2014; 23(2A):558–66.
3. Bijker MS, Melief CJ, Offringa R, van der Burg SH. Design and development of synthetic peptide vaccines: past, present and future. Expert Rev Vaccines 2007; 6(4):591–603.
4. Taha MA, Singh SR, Dennis VA. Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide. Nanotechnology 2012; 23(32):325101.
5. Mansuroğlu B, Derman S, Yaba A, Kızılbey K. Protective effect of chemically modified SOD on lipid peroxidation and antioxidant status in diabetic rats. Int J Biol Macromol 2015;72:79–87.
6. Mansuroglu B, Kizilbey K, Derman S, Mustafaeva Z. Investigation of protein-polyelectrolyte complex and conjugates by high performance liquid chromatography methods. Turk J Biochem 2011; 36(1):21–8.
7. Mustafaev M, Sarac A. Polyelectrolyte complexes (in immunology). In (Ed Salomone JC) The polymeric materials encyclopedia: synthesis, properties and application. CRC Press Inc, Boca Raton FL 1996. p. 5771–7.
8. Derman S, Kizilbey K, Mansuroglu B, Mustafaeva Z. Poly (N-Vinyl-2-Pyrrolidone-co-Acrylic Acid)-Bovine Serum Albumin Complex Formation Studied by HPLC and UV/Vis Spectroscopy. Rom Biotech Lett 2012; 17(4):7408–17.
9. Kizilbey K, Derman S, Mustafaeva Z. Poly (N-vinyl-2- pyrrolidone-co-acrylic acid): Comparing of “Traditional Heating” and “Microwave-Assisted” Free Radical Polymerization. J Chem Soc Pakistan 2013; 35(4):1191–6.
10. Hou Y, Gu XX. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates. J Immunol 2003; 170(8):4373–9.
11. May RJ, Beenhouwer DO, Scharff MD. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development. J Immunol 2003; 171(9):4905–12.
12. Ghosh I, Sun L, Evans TC Jr, Xu MQ. An improved method for utilization of peptide substrates for antibody characterization and enzymatic assays. J Immunol Methods 2004; 293(1-2):85–95.
13. Rubinchik E, Chow AW. Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1. Vaccine 2000; 18(21):2312–20.
14. Riemer AB, Klinger M, Wagner S, Bernhaus A, Mazzucchelli L, et al. Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu. J Immunol 2004; 173(1):394–401.
15. Coles DJ, Simerska P, Fujita Y, Toth I. The influence of incorporating lipids or liposaccharides on the particle size of peptide therapeutics. Biopolymers 2011; 96(2):172–6.
16. McMurray JS. The use of polyacrylamide-based peptide synthesis resins for the generation of antipeptide antibodies. Biopolymers 1998; 47(5):405–11.
17. Wong SS. Chemistry of protein conjugation and cross-linking. CRC Press Inc, Boca Raton FL 1991.
18. Akkilic N, Mustafaeva Z, Mustafaev M. High performance liquid chromatography study of water-soluble complexes and covalent conjugates of polyacrylic acid with bovine serum albumin. J Appl Polym Sci 2007; 105(5):3108–20.
19. Dilgimen AS, Mustafaeva Z, Demchenko M, Kaneko T, Osada Y, et al. Water-soluble covalent conjugates of bovine serum albumin with anionic poly(N-isopropyl-acrylamide) and their immunogenicity. Biomaterials 2001; 22(17):2383–92.
20. Mansuroglu B, Mustafaeva Z. Characterization of water-soluble conjugates of polyacrylic acid and antigenic peptide of FMDV by size exclusion chromatography with quadruple detection. Mater Sci Eng C 2012; 32(2):112–8.
21. Hermanson GT, Bioconjugate techniques. Academic press. San Diego 1996.
22. Cruz LJ, Iglesias E, Aguilar JC, Quintana D, Garay HE, et al. Study of different coupling agents in the conjugation of a V3-based synthetic MAP to carrier proteins. J Pept Sci 2001; 7(9):511–8
23. Gittings MR, Saville DA. The determination of hydrodynamic size and zeta potential from electrophoretic mobility and light scattering measurements. Colloid Surface A 1998; 141(1):111–7.
24. Wang CY, Chang TY, Walfield AM, Ye J, Shen M, et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine Vaccine 2002; 20(19-20):2603–10.
25. Volpina OM, Surovoy AY, Zhmak MN, Kuprianova MA, Koroev DO, et al. A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Vaccine 1999; 17(6):577–84.
26. Briand JP, Benkirane N, Guichard G, Newman JF, Van Regenmortel MH, et al. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. Proc Natl Acad Sci U S A 1997; 94(23):12545–50.
27. Park S, Hamad-Schifferli K. Evaluation of hydrodynamic size and zeta-potential of surface-modified an nanoparticle- DNA conjugates via Ferguson analysis. J Phys Chem C 2008; 112(20):7611–6.
28. Laaksonen T, Ahonen P, Johans C, Kontturi K. Stability and electrostatics of mercaptoundecanoic acid-capped gold nanoparticles with varying counterion size. Chemphyschem 2006; 7(10):2143–9.
29. Hanauer M, Pierrat S, Zins I, Lotz A, Sonnichsen C. Separation of nanoparticles by gel electrophoresis according to size and shape. Nano Lett 2007; 7(9):2881–5.
30. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODELnworkspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22(2):195-201.
31. Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 2003; 31(13):3381–5.
32. Bujacz A. Structures of bovine, equine and leporine serum albumin. Acta Crystallogr D Biol Crystallogr 2012; 68(Pt 10):1278–89.
33. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A 1996; 93(22):12349–54.